As the European Commission grants Marketing Authorization for the company's Ebola vaccine regimen—a key step towards enabling broader access to it for the people who need it most—we share top facts about the vaccine for the deadly virus.
Blog
One of the world's deadliest viral diseases was discovered in 1976 in Zaire, now known as the Democratic Republic of the Congo (DRC), near the Ebola River.
Since then, there have been 30 outbreaks of Ebola Virus Disease (EVD)—the worst of which hit in West Africa in 2014. During that two-year epidemic, more than 11,000 people died in Guinea, Liberia and Sierra Leone. Two in five individuals who were infected with the disease, then lost their lives.
As the International Aids Society Conference kicks off virtually this year, we sat down with three attendees, including activist and actress Laverne Cox, to talk about their groundbreaking work with HIV/AIDS in the midst of a global pandemic.
Blog
As the International Aids Society Conference kicks off virtually this year, we sat down with three attendees, including activist and actress Laverne Cox, to talk about their groundbreaking work with HIV/AIDS in the midst of a global pandemic.
Researchers investigating some of humanity’s most vexing diseases began reaching out 20 years ago to nerds, gamers and even giant high-tech corporations across the world, hoping to borrow unused time on their computers. They signed up thousands, who donated their computing power so the scientists could better research cancer, Alzheimer’s and the Ebola virus, among others.
Now those scientists have turned their attention to the new coronavirus.
Accelerated innovation. Resources in the hands of health workers. Profit returned to the frontline.
Learn more about how we #BackTheFrontline by investing in innovators developing scalable solutions to COVID-19 from Johnson & Johnson Impact Ventures Chair Joe Wolk.
Follow along with us on @JNJGlobalHealth on Twitter and/or Instagram to hear from our leaders, employees and partners around the world about how YOU can meaningfully contribute.
by Christa Myers, Process Engineer, and Marc Pelletier, PhD, Process Specialist
Blog
During a global pandemic, the pharmaceutical industry must juggle the need for speed and the need to protect patient safety. A strong regulatory strategy makes it possible to accelerate drug development without getting slowed down by compliance considerations.
Engaging our employees in our strong safety culture this Safety Month
Article
Tetra Tech’s employee participation and engagement are vital to the success of our Health & Safety program—we strive to engage more employees each year during Safety Month. We believe a successful safety program must include engaging employees in various safety processes at all levels.
When employees are well informed about safety practices in their workplace, they are more aware of their surroundings. Research shows that 70 percent fewer safety incidents occur in highly engaged workplaces, which is a win-win for both employees and employers.
Now more than ever, we recognize that your company needs to minimize business interruption, maintain business continuity, and build resilience for the future. This is especially critical for highly regulated industries like financial services, government, as well as healthcare and life sciences. Security and compliance have never been more important, especially as employees rapidly move to working remotely.
Funding supports efforts by National Organization for Rare Disorders (NORDⓇ) and Global Genes to address needs of the rare disease community arising from COVID-19 pandemic
Press Release
BOSTON, June 24, 2020 /3BL Media/ -- The Alexion Charitable Foundation, launched by Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) in February 2020, has announced it has awarded a total of $1.1 million in initial grants that align with its Rare Belonging® focus. Rare Belonging seeks to advance emotional well-being and educational opportunities, and provide relief for critical needs, for those living with or affected by a rare disease.
- Special Edition of Alkermes Inspiration Grants® Program Focused on Addressing Pandemic-Related Needs of People Living with Addiction, Serious Mental Illness, or Cancer -
Press Release
DUBLIN, June 24, 2020 /3BL Media/ -- Alkermes plc (Nasdaq: ALKS) today announced that 10 nonprofit organizations have been awarded grants from the company's COVID-19 Relief Fund, a special edition of the company's signature Alkermes Inspiration Grants® program, that was established to assist nonprofit organizations in their work to rapidly address pandemic-related needs for people living with addiction, serious mental illness, or cancer.
